Sign inJoin waitlistJoin the waitlist

Attaya Suvannasankha

Harry and Edith Gladstein Professor of Cancer Research · Indiana University School of Medicine

Credentials: · · ·

History

Indiana University School of Medicine
Present
Indiana University School of Medicine
Present

Research

Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study
The Lancet Oncology · 2020 · 657 citations
Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma
Blood · 2017 · 376 citations
Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting agents
Blood · 2023 · 192 citations

Rafat Abonour
16 papers
HL
Hans Lee
10 papers
Natalie Callander
8 papers
RB
Rachid Baz
8 papers
Sherif Farag
6 papers
Douglas Sborov
5 papers
MH
Malin Hultcrantz
5 papers
Thomas Martin
5 papers
Aaron Rosenberg
4 papers
Adam Cohen
4 papers
Ajai Chari
4 papers
Ajay Nooka
4 papers

Grants

Preclinical Validation of Adjuvant Fingolimod to Increase Efficacy of Proteasome Inhibitors for Treatment of Multiple Myeloma
Department of Veterans Affairs · I01
Contact PI · Rlr Va Medical Center
2012–2028
A Novel Agent to Suppress Tumor Growth in Bone, Prevent Cachectic Muscle Loss and Preserve Skeletal Integrity
Department of Veterans Affairs · I01
PI · Rlr Va Medical Center
2019–2023
Role of Osteocytes in Myeloma Bone Disease
Department of Veterans Affairs · I01
PI · Rlr Va Medical Center
2014–2018

Clinical trials

Frailty Score-guided Dosing of Lenalidomide, Dexamethasone and Daratumumab Induction Therapy
Principal investigator · Withdrawn · Phase 2
Attaya Suvannasankha
2021–2023
The Indiana Myeloma Registry
Principal investigator · Recruiting
Indiana University
2018–2028
Role of Osteocytes in Myeloma Bone Disease
Principal investigator · Completed
Attaya Suvannasankha
2014–2022
Carfilzomib in Treating Patients With Multiple Myeloma in First Relapse or Refractory to First-Line Therapy
Principal investigator · Terminated · Phase 2
Attaya Suvannasankha
2013–2016